Table 1.

Baseline characteristics for patients using biocompatible or standard solutions

CharacteristicBiocompatible Solutions, n=71Standard Solutions, n=295
Measures per person6.4 (0.45)7.3 (0.21)
Time to end of PD, yr2.6 (2.0–3.9)3.5 (2.2–4.8)
Time to first measure, yr0.52 (0.28–0.64)0.53 (0.41–0.62)
Baseline measurements for fixed covariates
 Age, yr55 (14)54 (15)
 Men, %5059
 Comorbidity score, low/medium/high, %48/46/640/52/8
 Dialysate IL-6 (log transformed), pg/ml4.8 (1.8–12.9)4.5 (1.5–10.8)
 Plasma IL-6 (log transformed), pg/ml1.3 (0.64–2.4)1.3 (0.7–2.5)
 APD usage compared with CAPD usage, %628
 Country, Canada/United Kingdom/Korea1/35/3516/163/116
 Weight, kg63 (55–76)67 (58–77)
Baseline measurements for time-varying covariates
 Average dialysate dextrose concentration, g/L15.0 (15.0–18.7)15.0 (15.0–20.1)
 Urine volume, L0.96 (0.55–1.52)0.86 (0.4–1.4)
 Icodextrin use, %2933
 Peritonitis count, no. of episodes per 1 yr0 (0–0.59)0.23 (0–0.47)
  • Baseline measurements are shown as mean with SD or median with interquartile range. Characteristics of patients who were excluded for using both biocompatible and standard solutions are included in Supplemental Table 1. PD, peritoneal dialysis; APD, automated peritoneal dialysis; CAPD, continuous ambulatory peritoneal dialysis.